Research
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4944 (Published 07 August 2012) Cite this as: BMJ 2012;345:e4944Data supplement
Web Extra
Appendix: Search strings used in literature search (as supplied by the author)
Files in this Data Supplement:
Related articles
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921
- Research Methods & Reporting Published: 22 July 2011; BMJ 343 doi:10.1136/bmj.d4002
- Paper Published: 21 July 2001; BMJ 323 doi:10.1136/bmj.323.7305.131
- Research Published: 25 October 2011; BMJ 343 doi:10.1136/bmj.d6423
- Research Article Published: 22 February 1986; Br Med J (Clin Res Ed) 292 doi:10.1136/bmj.292.6519.526
- Practice Published: 08 October 2015; BMJ 351 doi:10.1136/bmj.h4847
See more
- Surrogates have higher risk of pregnancy complications, research findsBMJ September 25, 2024, 386 q2100; DOI: https://doi.org/10.1136/bmj.q2100
- Two thirds of maternity units fail to meet safety standards as poor care is “normalised,” says regulatorBMJ September 19, 2024, 386 q2051; DOI: https://doi.org/10.1136/bmj.q2051
- US women must be told breast density after mammogram, says FDABMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045
- Harris and Trump clash over abortion in presidential debateBMJ September 12, 2024, 386 q2003; DOI: https://doi.org/10.1136/bmj.q2003
- Valproate: Men are advised to use contraception owing to risk of neurodevelopmental disorders in childrenBMJ September 06, 2024, 386 q1957; DOI: https://doi.org/10.1136/bmj.q1957
Cited by...
- Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry
- FSRH Guideline (August 2022) Progestogen-only Pills
- Womens health in The BMJ: a data science history
- Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study
- Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland
- FSRH Guideline (April 2019) Overweight, Obesity and Contraception
- Associations of hormonal contraceptives and infertility medications on the risk of venous thromboembolism, ischemic stroke, and cardiovascular disease in women
- How I diagnose and treat venous thromboembolism in sickle cell disease
- How I treat heavy menstrual bleeding associated with anticoagulants
- Pregnancy in pulmonary arterial hypertension
- Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
- Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study
- Contraceptive and hormonal treatment options for women with history of venous thromboembolism
- Trends in family planning and counselling for women with sickle cell disease in the UK over two decades
- New insights into treatment of venous thromboembolism
- Contraceptive options for women with SLE: response to Mansour letter
- DTB Select: 10 | October 2012
- Minimizing Risk for Thromboembolic Events Associated with Hormonal Contraception